• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1990 - 2021年东南亚国家联盟(东盟)各国吸烟的流行病学与负担:全球疾病负担研究2021的结果

The epidemiology and burden of smoking in countries of the Association of Southeast Asian Nations (ASEAN), 1990-2021: findings from the Global Burden of Disease Study 2021.

出版信息

Lancet Public Health. 2025 Jun;10(6):e442-e455. doi: 10.1016/S2468-2667(24)00326-8.

DOI:10.1016/S2468-2667(24)00326-8
PMID:40441812
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12127265/
Abstract

BACKGROUND

Tobacco smoking has long been a regional health priority for the Association of Southeast Asian Nations (ASEAN). Despite decades of commitment to implementing tobacco control measures, the ASEAN region continues to face substantial challenges in reversing the epidemic. We aimed to analyse longitudinal data on smoking prevalence and attributable disease burden to understand the trajectory of the smoking epidemic, inform priority setting, and enable effective policy planning.

METHODS

We used data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 to evaluate the prevalence of tobacco smoking and its attributable disease burden in the ten ASEAN member states by age and sex, from 1990 to 2021. Current smoking prevalence was estimated using spatiotemporal Gaussian process regression models, which synthesised data from 159 distinctive data sources specific to the ASEAN region in addition to 2646 data sources from other GBD countries. Dose-response risks for 36 health outcomes were derived using the latest burden of proof approach. Population attributable fractions were subsequently calculated and applied to determine the burden in terms of mortality, years of life lost, years lived with disability, and disability-adjusted life-years (DALYs) attributable to tobacco smoking in these countries.

FINDINGS

In 2021, there were approximately 137 million (95% uncertainty interval 134-139) current smokers aged 15 years and older in the ASEAN region, with an estimated age-standardised prevalence of 48·4% (47·5-49·2) among males and 4·47% (4·09-4·92) among females. Tobacco smoking accounted for 10·8% (8·86-12·9) of all-cause mortality across the region. The total number of deaths and DALYs attributed to smoking were 526 000 deaths (433 000-622 000) and 15·7 million (12·9-18·5) DALYs. Death rates varied considerably across the region, especially among males, ranging from 68·9 (55·8-84·2) per 100 000 males in Singapore to 364 (279-463) per 100 000 males in Cambodia. Although smoking prevalence declined substantially in most ASEAN countries between 1990 and 2021, the absolute number of smokers increased by 63·3% (59·0-67·8), and the number of smokers aged 10 years and older increased by 53·0 million (50·2-56·2).

INTERPRETATION

Tobacco smoking remains a persistent public health threat in the ASEAN region. Considerable disparities exist across the region: while some countries have made remarkable progress in tobacco control, others lag behind. As a modifiable risk factor heavily influenced by commercial determinants, smoking can be controlled through effective policy changes. As a geopolitical and economic collaboration network, ASEAN countries must work together to overcome barriers hindering anti-tobacco efforts and collectively devise strategies to strengthen tobacco control across the region.

FUNDING

Bloomberg Philanthropies and the Bill & Melinda Gates Foundation.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80bd/12127265/0bcbea3fa366/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80bd/12127265/9c6b6cfa9a2d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80bd/12127265/9bc3c40d7125/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80bd/12127265/e7bfd5a54192/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80bd/12127265/0bcbea3fa366/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80bd/12127265/9c6b6cfa9a2d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80bd/12127265/9bc3c40d7125/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80bd/12127265/e7bfd5a54192/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80bd/12127265/0bcbea3fa366/gr4.jpg
摘要

背景

长期以来,吸烟一直是东南亚国家联盟(东盟)区域卫生工作的重点。尽管数十年来致力于实施烟草控制措施,但东盟地区在扭转这一流行趋势方面仍面临重大挑战。我们旨在分析吸烟流行率和可归因疾病负担的纵向数据,以了解吸烟流行的轨迹,为确定优先事项提供信息,并实现有效的政策规划。

方法

我们使用了《2021年全球疾病、伤害和风险因素负担研究》(GBD 2021)的数据,以评估1990年至2021年期间东盟十个成员国按年龄和性别的吸烟流行率及其可归因疾病负担。当前吸烟流行率采用时空高斯过程回归模型进行估计,该模型综合了东盟地区159个独特数据源以及其他GBD国家的2646个数据源的数据。使用最新的证据负担方法得出36种健康结局的剂量反应风险。随后计算人群归因分数,并应用于确定这些国家因吸烟导致的死亡率、寿命损失年数、带病生存年数和伤残调整生命年(DALY)负担。

结果

2021年,东盟地区15岁及以上的当前吸烟者约有1.37亿(95%不确定区间为1.34 - 1.39亿),估计年龄标准化患病率在男性中为48.4%(47.5 - 49.2),在女性中为4.47%(4.09 - 4.92)。吸烟占该地区全因死亡率的10.8%(8.86 - 12.9)。归因于吸烟的死亡总数和DALY分别为52.6万例(43.3万 - 62.2万)和1570万(1290万 - 1850万)。该地区的死亡率差异很大,尤其是男性,从新加坡每10万男性中的68.9例(55.8 - 84.2)到柬埔寨每10万男性中的364例(279 - 463)不等。尽管1990年至2021年期间大多数东盟国家的吸烟流行率大幅下降,但吸烟者的绝对数量增加了{63.3%}(59.0 - 67.8),10岁及以上吸烟者的数量增加了5300万(5020万 - 5620万)。

解读

吸烟在东盟地区仍然是持续存在的公共卫生威胁。该地区存在相当大的差异:虽然一些国家在烟草控制方面取得了显著进展,但其他国家则滞后。作为一个受商业因素严重影响的可改变风险因素,吸烟可以通过有效的政策变革加以控制。作为一个地缘政治和经济合作网络,东盟国家必须共同努力克服阻碍控烟工作的障碍,并共同制定加强该地区烟草控制的战略。

资金来源

彭博慈善基金会和比尔及梅琳达·盖茨基金会。

相似文献

1
The epidemiology and burden of smoking in countries of the Association of Southeast Asian Nations (ASEAN), 1990-2021: findings from the Global Burden of Disease Study 2021.1990 - 2021年东南亚国家联盟(东盟)各国吸烟的流行病学与负担:全球疾病负担研究2021的结果
Lancet Public Health. 2025 Jun;10(6):e442-e455. doi: 10.1016/S2468-2667(24)00326-8.
2
The epidemiology and burden of injury in countries of the Association of Southeast Asian Nations (ASEAN), 1990-2021: findings from the Global Burden of Disease Study 2021.1990 - 2021年东南亚国家联盟(东盟)各国的伤害流行病学与负担:全球疾病负担研究2021的结果
Lancet Public Health. 2025 Jun;10(6):e456-e466. doi: 10.1016/S2468-2667(25)00069-6.
3
The epidemiology and burden of ten mental disorders in countries of the Association of Southeast Asian Nations (ASEAN), 1990-2021: findings from the Global Burden of Disease Study 2021.1990 - 2021年东南亚国家联盟(东盟)各国十种精神障碍的流行病学与负担:全球疾病负担研究2021的结果
Lancet Public Health. 2025 Jun;10(6):e480-e491. doi: 10.1016/S2468-2667(25)00098-2.
4
The epidemiology and burden of cardiovascular diseases in countries of the Association of Southeast Asian Nations (ASEAN), 1990-2021: findings from the Global Burden of Disease Study 2021.1990 - 2021年东南亚国家联盟(东盟)各国心血管疾病的流行病学与负担:全球疾病负担研究2021的结果
Lancet Public Health. 2025 Jun;10(6):e467-e479. doi: 10.1016/S2468-2667(25)00087-8.
5
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家 84 种行为、环境、职业和代谢风险以及 195 个国家和地区 1990 至 2017 年风险簇的比较风险评估:全球疾病负担研究 2017 系统分析。
Lancet. 2018 Nov 10;392(10159):1923-1994. doi: 10.1016/S0140-6736(18)32225-6. Epub 2018 Nov 8.
6
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015.1990-2015 年 195 个国家和地区的吸烟流行率和可归因疾病负担:来自 2015 年全球疾病负担研究的系统分析。
Lancet. 2017 May 13;389(10082):1885-1906. doi: 10.1016/S0140-6736(17)30819-X. Epub 2017 Apr 5.
7
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球疾病、伤害和危险因素负担研究 2021 年,1990-2021 年全球 204 个国家和地区及 811 个次国家地区 371 种疾病和伤害的发病率、患病率、伤残损失生命年(YLDs)、伤残调整生命年(DALYs)以及健康期望寿命(HALE):系统分析
Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17.
8
The burden of diseases, injuries, and risk factors by state in the USA, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.1990 - 2021年美国各州疾病、伤害及风险因素负担:《2021年全球疾病负担研究》的系统分析
Lancet. 2024 Dec 7;404(10469):2314-2340. doi: 10.1016/S0140-6736(24)01446-6.
9
Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 87 种风险因素的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1223-1249. doi: 10.1016/S0140-6736(20)30752-2.
10
Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.204 个国家和地区 2022-2050 年疾病负担情景:2021 年全球疾病负担研究的预测分析。
Lancet. 2024 May 18;403(10440):2204-2256. doi: 10.1016/S0140-6736(24)00685-8.

本文引用的文献

1
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.204 个国家和地区及 811 个次国家级行政单位 1950 年至 2021 年的全球年龄、性别特异性死亡率、预期寿命和人口估计,以及 COVID-19 大流行的影响:2021 年全球疾病负担研究的综合人口分析。
Lancet. 2024 May 18;403(10440):1989-2056. doi: 10.1016/S0140-6736(24)00476-8. Epub 2024 Mar 11.
2
Prevalence and Covariates of Electronic Cigarette Use among Students Aged 13-15 Years in the Philippines: 2019 Global Youth Tobacco Survey.菲律宾 13-15 岁学生电子烟使用情况的流行率及相关因素:2019 年全球青年烟草调查。
Int J Environ Res Public Health. 2023 Dec 18;20(24):7193. doi: 10.3390/ijerph20247193.
3
Policy incoherence and unwillingness of the Indonesian government to curb its alarming tobacco epidemic.印度尼西亚政府在政策上缺乏连贯性,且不愿遏制该国令人担忧的烟草流行情况。
Tob Control. 2023 Jul;32(4):405-406. doi: 10.1136/tc-2023-058114.
4
Tobacco industry influence in low- and middle-income countries in the ASEAN region: Qualitative interviews with tobacco control experts during the COVID-19 pandemic.烟草行业对东盟地区低收入和中等收入国家的影响:在新冠疫情期间对烟草控制专家进行的定性访谈
Tob Induc Dis. 2022 Dec 6;20:108. doi: 10.18332/tid/155391. eCollection 2022.
5
Electronic cigarettes use and 'dual use' among the youth in 75 countries: estimates from Global Youth Tobacco Surveys (2014-2019).电子香烟在 75 个国家的青少年中的使用情况和“双重使用”:全球青少年烟草调查(2014-2019 年)的估计。
Sci Rep. 2022 Dec 5;12(1):20967. doi: 10.1038/s41598-022-25594-4.
6
Health effects associated with smoking: a Burden of Proof study.与吸烟相关的健康影响:一项证明负担的研究。
Nat Med. 2022 Oct;28(10):2045-2055. doi: 10.1038/s41591-022-01978-x. Epub 2022 Oct 10.
7
The Burden of Proof studies: assessing the evidence of risk.举证责任研究:评估风险证据。
Nat Med. 2022 Oct;28(10):2038-2044. doi: 10.1038/s41591-022-01973-2. Epub 2022 Oct 10.
8
Magnitude of illicit cigarette trade in Malaysia: empirical evidence compared with industry studies.马来西亚非法香烟贸易的规模:与行业研究的实证比较。
Tob Control. 2024 Apr 19;33(3):341-345. doi: 10.1136/tc-2021-057210.
9
Tobacco and electronic cigarette smoking among in-school adolescents in Vietnam between 2013 and 2019: prevalence and associated factors.2013 年至 2019 年越南在校青少年的烟草和电子烟使用情况:流行率及相关因素。
Glob Health Action. 2022 Dec 31;15(1):2114616. doi: 10.1080/16549716.2022.2114616.
10
Longitudinal bidirectional association between youth electronic cigarette use and tobacco cigarette smoking initiation in Thailand.泰国青少年使用电子烟与开始吸食传统香烟之间的纵向双向关联。
Tob Control. 2024 Apr 19;33(3):310-316. doi: 10.1136/tc-2022-057491.